Healthcare
Live Price
Offline$0.75
-3.23% today
1Y Change
-89.16%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Zhengye Biotechnology Holding Limited (ZYBT) is a Healthcare stock with a market cap of $320.00M and listed on NASDAQ. The stock last traded around $0.75 and down 89.2% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of -37.6%, EPS growth of -100.0%, a dividend yield of 0.0%. What stands out right now is revenue -37.6%, EPS -100.0%, free cash flow -94.7% with operating margin -58.7% and ROIC -17.9%. Valuation is more restrained than many high-expectation growth names at price/sales 2.8. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines ZYBT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ZYBT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
ZYBT Max Drawdown
-94.39%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for ZYBT and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.